相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autoradiography, MALDI-MS, and SIMS-MS Imaging in Pharmaceutical Discovery and Development
Eric G. Solon et al.
AAPS JOURNAL (2010)
Rate and Extent of Drug Accumulation after Multiple Dosing Revisited
Dion R. Brocks et al.
CLINICAL PHARMACOKINETICS (2010)
Relations between toxicity and altered tissue distribution and urinary excretion of nicotine, cotinine, and hydroxycotinine after chronic oral administration of nicotine in rats
Ki Young Kim et al.
DRUG AND CHEMICAL TOXICOLOGY (2010)
Metabolic Disposition of Casopitant, a Potent Neurokinin-1 Receptor Antagonist, in Mice, Rats, and Dogs
Lidia Miraglia et al.
DRUG METABOLISM AND DISPOSITION (2010)
Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates
Simone Braggio et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy
Gregory M. Palmer et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Imaging Mass Spectrometry for Visualization of Drug and Endogenous Metabolite Distribution: Toward In Situ Pharmacometabolomes
Yuki Sugiura et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Modelling and PBPK Simulation in Drug Discovery
Hannah M. Jones et al.
AAPS JOURNAL (2009)
Lack of stability of topotecan in heart tissue homogenates: is it an analytical dilemma or a real phenomenon?
Nuggehally R. Srinivas
BIOMEDICAL CHROMATOGRAPHY (2009)
Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity
Carmelo Lafuente-Lafuente et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing
Robert Espina et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Physiologically based pharmacokinetics (PBPK)
Pascal Espie et al.
DRUG METABOLISM REVIEWS (2009)
Tachykinin receptor antagonists in clinical trials
Laura Quartara et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Casopitant: a new warrior in the antiemetic crusade
Ali Khojasteh et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
Jorn Herrstedt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Imaging Mass Spectrometry: Hype or Hope?
Ron M. A. Heeren et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2009)
Toxicity Testing in the 21st Century: Bringing the Vision to Life
Melvin E. Andersen et al.
TOXICOLOGICAL SCIENCES (2009)
Post-mortem clinical pharmacology
R. E. Ferner
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Evaluation of preparative high performance liquid chromatography and cryoprobe-nuclear magnetic resonance spectroscopy for the early quantitative estimation of drug metabolites in human plasma
G. J. Dear et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Requirements for bioanalytical procedures in postmortem toxicology
Olaf H. Drummer
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Mechanism for covalent binding of rofecoxib to elastin of rat aorta
Masataka Oitate et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Impact of differential recovery in bioanalysis: The example of bortezomib in whole blood
Adam H. Brockman et al.
ANALYTICAL CHEMISTRY (2007)
Autoradiography: high-resolution molecular imaging in pharmaceutical discovery and development
Eric G. Solon
EXPERT OPINION ON DRUG DISCOVERY (2007)
Complicating factors in safety testing of drug metabolites: Kinetic differences between generated and preformed metabolites
Thomayant Prueksaritanont et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Differential sensitivity of rat kidney and liver to fumonisin toxicity: Organ-specific differences in toxin accumulation and sphingoid base metabolism
Ronald T. Riley et al.
TOXICOLOGICAL SCIENCES (2006)
Drug-induced phospholipidosis: issues and future directions
Mark J. Reasor et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Tissue distribution and pharmacodynamics: A complicated relationship
JH Lin
CURRENT DRUG METABOLISM (2006)
Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT)
WJ Rogan et al.
LANCET (2005)
Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective
CJ Lin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Drug tissue distribution: Study methods and therapeutic implications
JM Lanao et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Methods to assess tissue-specific distribution and metabolism of drugs
O Langer et al.
CURRENT DRUG METABOLISM (2004)
Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence
SL Vonderfecht et al.
TOXICOLOGIC PATHOLOGY (2004)
Postmortem drug analysis: Analytical and toxicological aspects
OH Drummer et al.
THERAPEUTIC DRUG MONITORING (2002)
Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes
RJ Gum et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Gene expression in distinct regions of the heart
T Thum et al.
LANCET (2000)
In-vitro metabolism of retinoic acid by different tissues from male rats
M Ahmad et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
分享论文
